We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
JAK inhibitor: Introduction.
- Authors
Raychaudhuri, Siba P.; Raychaudhuri, Smriti K.
- Abstract
The Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway is a key regulatory signaling system for cellular proliferation, differentiation, and apoptosis. In addition, JAK signaling pathway plays critical roles in orchestrating immune response through its interactions with the cytokine receptors and the transcriptions factors. Several key cytokines use JAK-STAT signaling proteins to transduce intra-cellular signals which are involved in the pathogenesis of autoimmune and inflammatory diseases such as in psoriatic disease (psoriasis, psoriatic arthritis), atopic dermatitis, alopecia areata, vitiligo, rheumatoid arthritis, ankylosing spondylitis, lupus erythematosus, Sjogren's syndrome, and other autoimmune diseases. In recent years, understandings of the molecular mechanisms of JAK-STAT pathway in the inflammatory proliferative cascades of autoimmune diseases has led to the development of JAK inhibitors and has opened a new dimension for the treatment of systemic and cutaneous inflammatory diseases. In this symposium we have provided a broad perspective on the use of Janus kinase inhibitors in cutaneous autoimmune diseases.
- Subjects
AUTOIMMUNE diseases; SJOGREN'S syndrome; SKIN diseases; LUPUS erythematosus; JAK-STAT pathway; CYTOKINE receptors; TRANSCRIPTION factors
- Publication
Indian Journal of Dermatology, Venereology & Leprology, 2023, Vol 89, Issue 5, p688
- ISSN
0378-6323
- Publication type
Article
- DOI
10.25259/IJDVL_8_2023